多基因风险评分与帕金森病认知和运动进展的关联
结果显示PRS与更快的认知下降和运动进展显著相关,提示这些遗传标志物不仅与帕金森病易感性相关,还可能影响多领域疾病进展。
要点
- PRS与帕金森病患者更快的认知下降显著相关(HR 1.44,95%CI 1.00-2.07)。
- PRS与更快的运动进展相关,至Hoehn & Yahr 3期HR 1.34(95%CI 1.00-1.79)。
- PRS与UPDRS第三部分评分变化相关(HR 1.42,95%CI 1.00-2.01)。
核心结论
- 帕金森病易感性SNP构建的累积PRS与患者更快的运动和认知下降相关。
- 这些遗传标志物可能不仅与帕金森病易感性相关,还与多领域疾病进展相关。
研究设计与样本
- 纵向基于人群的队列研究,纳入285例欧洲裔散发性帕金森病患者,对23个GWAS SNP进行基因分型。
- 采用Cox比例风险回归模型和逆概率加权处理删失。
主要发现
- 加权PRS与更快的认知下降显著相关,以简易精神状态检查变化衡量(每1 SD的HR 1.44;95%CI 1.00-2.07)。
- PRS与更快的运动下降相关,以至Hoehn & Yahr量表3期时间衡量(HR 1.34;95%CI 1.00-1.79)。
- PRS与统一帕金森病评定量表第三部分评分变化相关(HR 1.42;95%CI 1.00-2.01)。
临床怎么用
- PRS可能有助于识别帕金森病患者中认知和运动进展更快的个体。
- 遗传标志物或可用于帕金森病疾病进展的多领域风险评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Genetic factors have a well-known influence on Parkinson disease (PD) susceptibility. The largest genome-wide association study (GWAS) identified 26 independent single-nucleotide polymorphisms (SNPs) associated with PD risk. Among patients, the course and severity of symptom progression is variable, and little is known about the potential association of genetic factors with phenotypic variance. OBJECTIVE: To assess whether GWAS-identified PD risk SNPs also have a cumulative association with the progression of cognitive and motor symptoms in patients with PD. DESIGN, SETTING, AND PARTICIPANTS: This longitudinal population-based cohort study of 285 patients of European ancestry with incident PD genotyped 23 GWAS SNPs. One hundred ninety-nine patients were followed up for a mean (SD) of 5.3 (2.1) years for progression (baseline: June 1, 2001, through November 31, 2007; follow-up: June 1, 2007, through August 31, 2013, with mortality surveillance through December 31, 2016); 57 patients had died or were too ill for follow-up, and 29 withdrew or could not be contacted. Movement disorder specialists repeatedly assessed PD symptom progression. MAIN OUTCOMES MEASURES: The combined association of PD risk loci, after creating a weighted polygenic risk score (PRS), with cognitive decline, motor progression, and survival, relying on Cox proportional hazards regression models and inverse probability weights to account for censoring. RESULTS: Of the 285 patients undergoing genotyping, 160 were men (56.1%) and 125 were women (43.9%); the mean (SD) age at diagnosis was 69.1 (10.4) years. The weighted PRS was associated with significantly faster cognitive decline, measured by change in the Mini-Mental State Examination (hazard ratio [HR] per 1 SD, 1.44; 95% CI, 1.00-2.07). The PRS was also associated with faster motor decline, measured by time to Hoehn & Yahr Scale stage 3 (HR, 1.34; 95% CI, 1.00-1.79) and change in Unified Parkinson's Disease Rating Scale part III score (HR, 1.42; 95% CI, 1.00-2.01). CONCLUSIONS AND RELEVANCE: Susceptibility SNPs for PD combined with a cumulative PRS were associated with faster motor and cognitive decline in patients. Thus, these genetic markers may be associated with not only PD susceptibility but also disease progression in multiple domains.
引用
- Paul KC, Schulz J, Bronstein JM, et al. Association of Polygenic Risk Score With Cognitive Decline and Motor Progression in Parkinson Disease. JAMA Neurol. 2018. PMID: 29340614. doi:10.1001/jamaneurol.2017.4206
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。